These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 21916523)
1. A concise synthesis of a β-lactamase inhibitor. Mangion IK; Ruck RT; Rivera N; Huffman MA; Shevlin M Org Lett; 2011 Oct; 13(20):5480-3. PubMed ID: 21916523 [TBL] [Abstract][Full Text] [Related]
2. Practical and cost-effective manufacturing route for the synthesis of a β-lactamase inhibitor. Miller SP; Zhong YL; Liu Z; Simeone M; Yasuda N; Limanto J; Chen Z; Lynch J; Capodanno V Org Lett; 2014 Jan; 16(1):174-7. PubMed ID: 24329136 [TBL] [Abstract][Full Text] [Related]
3. Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors. Coleman K Curr Opin Microbiol; 2011 Oct; 14(5):550-5. PubMed ID: 21840248 [TBL] [Abstract][Full Text] [Related]
4. New β-lactam antibiotics and β-lactamase inhibitors. Bush K; Macielag MJ Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927 [TBL] [Abstract][Full Text] [Related]
5. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. Weston GS; Blázquez J; Baquero F; Shoichet BK J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697 [TBL] [Abstract][Full Text] [Related]
6. Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®. Blizzard TA; Chen H; Kim S; Wu J; Bodner R; Gude C; Imbriglio J; Young K; Park YW; Ogawa A; Raghoobar S; Hairston N; Painter RE; Wisniewski D; Scapin G; Fitzgerald P; Sharma N; Lu J; Ha S; Hermes J; Hammond ML Bioorg Med Chem Lett; 2014 Feb; 24(3):780-5. PubMed ID: 24433862 [TBL] [Abstract][Full Text] [Related]
7. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis. Dinçer I; Ergin A; Kocagöz T Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094 [TBL] [Abstract][Full Text] [Related]
12. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Brauers J; Frank U; Kresken M; Rodloff AC; Seifert H Clin Microbiol Infect; 2005 Jan; 11(1):24-30. PubMed ID: 15649300 [TBL] [Abstract][Full Text] [Related]
14. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations. Buynak JD Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643 [TBL] [Abstract][Full Text] [Related]
15. Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamases. Johnson JW; Gretes M; Goodfellow VJ; Marrone L; Heynen ML; Strynadka NC; Dmitrienko GI J Am Chem Soc; 2010 Mar; 132(8):2558-60. PubMed ID: 20141132 [TBL] [Abstract][Full Text] [Related]
16. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics. Ishiguro M; Tanaka R; Namikawa K; Nasu T; Inoue H; Nakatsuka T; Oyama Y; Imajo S J Med Chem; 1997 Jul; 40(14):2126-32. PubMed ID: 9216830 [TBL] [Abstract][Full Text] [Related]
17. The impact of beta-lactamases on the development of novel antimicrobial agents. Bush K Curr Opin Investig Drugs; 2002 Sep; 3(9):1284-90. PubMed ID: 12498001 [TBL] [Abstract][Full Text] [Related]